Kingdon Capital Management, L.L.C. Enanta Pharmaceuticals Inc Transaction History
Kingdon Capital Management, L.L.C.
- $834 Million
- Q3 2024
A detailed history of Kingdon Capital Management, L.L.C. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 150,000 shares of ENTA stock, worth $747,000. This represents 1.29% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$747,000% of portfolio
1.29%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ENTA
# of Institutions
111Shares Held
21.2MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$10.5 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$9.87 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$9.2 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$7.46 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$5.49 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $103M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...